First non-ATP competitive glycogen synthase kinase 3 β (GSK-3β) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease

  1. Martinez, A.
  2. Alonso, M.
  3. Castro, A.
  4. Pérez, C.
  5. Moreno, F.J.
Journal:
Journal of Medicinal Chemistry

ISSN: 0022-2623

Year of publication: 2002

Volume: 45

Issue: 6

Pages: 1292-1299

Type: Article

DOI: 10.1021/JM011020U GOOGLE SCHOLAR
Data source: Scopus